Analysts’ Viewpoint
Cardiac implantable electronic devices (CIEDs) are an integral part of cardiology in general and electrophysiology in particular. Cardiovascular implantable electronic devices have become established treatments for various cardiac arrhythmias. Large geriatric population with cardiac diseases is driving the demand for CIEDs. Advancement in lead and device technology, simplification of the implant technique, and rise in demand for cardiac implanted electronic devices for continuous heart monitoring and to support heart functionality are the major factors propelling the global cardiac implantable electronic devices market size.
Companies are striving to introduce new products to meet the growing demand for implantable devices. The size of these devices has been reduced significantly in the past few years in order to promote minimally invasive surgery that is less risky and a convenient option for patients.
CIEDs are sophisticated modern devices that provide patients with several beneficial effects such as increased survival and enhanced quality of life. Cardiovascular implantable electronic devices include pacemakers, implantable cardioverter defibrillators (ICDs), and loop recorders. Pacemaker is a small device placed in abdomen or chest. It is used in case of slower heart rate than normal. Implantable cardioverter defibrillators (ICDs) are used if the heart beats way too faster than normal. Loop recorder records the rhythm of the heart.
Ambulatory cardiac monitoring devices assist in continuous monitoring of the heart, allowing the detection of chronic heart conditions such as stroke and heart failure. Focus on functional and structural abnormalities of the arteries and heart makes it possible to identify and track disease progression.
According to the American Heart Association's 2017 Heart Diseases and Stroke Statistics update, the number of people diagnosed with heart failure is rising and will increase by 46% by 2030, resulting in more than 8 million people suffering from heart failure. Globally, 22 million people suffer from congestive heart failure, with an additional 2 million diagnosed each year. Thus, rise in number of cardiac patients who suffer from chronic heart diseases is expected to fuel market expansion.
Technological advancements have paved the way for innovative subcutaneous version of cardiac monitoring devices for better alertness of cardiac patients, which helps them prevent cardiac stroke and other complicated conditions. Usage of implantable cardiac monitors (ICMs), also known as implantable electronic loop recorders (ILRs), has increased. These devices keep track of the irregularity of heart rhythm. ICMs are small subcutaneous devices that monitor the heart rhythm and record events for a number of years.
Insertable cardiac monitors are primarily used to monitor patients with syncope or stroke of unknown origin, and infrequent rhythm abnormalities. They are also used for long-term monitoring of atrial fibrillation post ablation. Insertable cardiac monitors (ICMs) are small, subcutaneously implanted devices offering continuous ambulatory electrocardiogram (ECG) monitoring with a lifespan of up to three years. Increase in demand for implantable cardiac electronic devices is accelerating industry expansion due to the continuous monitoring of irregular cardiac rhythms.
In terms of product, the global cardiac implantable electronic device market has been classified into pacemakers, implantable cardioverter defibrillators, and implantable cardiac loop recorders. The implantable cardioverter defibrillators segment dominated the global business in 2021 owing to large number of users. However, the implantable loop recorders segment is likely to grow at a faster pace during the forecast period.
Continuous monitoring of health status of a heart patient is crucial. Development and usage of wireless communication technologies, wearable detecting devices, and small energy consumption microchips with high efficiency data handling algorithms have made continuous monitoring possible with implantable loop recorder devices. Thus, rise in demand for continuous monitoring of heart activities is driving the implantable loop recorders segment.
Based on end-user, the hospitals segment accounted for more than 60.0% share of the global cardiac implantable electronic device market in 2021. The segment is anticipated to grow rapidly in the near future in Asia Pacific and the Middle East due to availability of a range of products and treatments under one roof. The segment is likely to lose market share in North America owing to the rise in preference for ambulatory centers in the region.
North America held significant share of the industry in 2021 due to rise in awareness about CIEDs and availability of advanced products in the region.
Increase in chronic diseases among the geriatric population, growth in awareness about the benefits of CIEDs in countries such as India and Indonesia, and surge in government investments in healthcare systems in countries in South Asia are anticipated to augment the business in Asia Pacific in the next few years.
The global cardiac implantable electronic device market is consolidated, with the presence of small number of players. Key players operating in the industry are Abbott, Medtronic plc, Boston Scientific Corporation, Biotronic AG, Angel Medical Systems, Inc., MicroPort, Cook Medical, Inc., Lepu Medical Technology(Beijing) Co., Ltd., Vitatron, and MEDICO S.R.L.
Leading players have adopted strategies such as new product development, product approvals, product launches, partnerships, and mergers.
These players have been profiled in the cardiac implantable electronic device market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 10.8 Bn |
|
Forecast (Value) in 2031 |
More than US$ 16.1 Bn |
|
Growth Rate (CAGR) |
3.6% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, etc. |
|
Competition Landscape |
Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials |
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The industry was valued at US$ 10.8 Bn in 2021.
It is projected to reach more than US$ 16.1 Bn by 2031.
The CAGR is anticipated be 3.6% from 2022 to 2031.
Rise in cardiac disease prevalence among aging population and increase in launch of innovative products.
The implantable cardioverter defibrillators segment held more than 50.0% share in 2021.
North America is expected to account for major share from 2022 to 2031.
Abbott, Medtronic plc, Boston Scientific Corporation, Biotronic AG, Angel Medical Systems, Inc., MicroPort, Cook Medical, Inc., Lepu Medical Technology (Beijing) Co., Ltd., Vitatron, and MEDICO S.R.L.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cardiac Implantable Electronic Device Market
4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, 2017–2031
4.3.1. Global Cardiac Implantable Electronic Device Market Revenue Projection (US$ Mn)
5. Market Outlook
5.1. Technological Advancement
5.2. Cardiovascular Disease Prevalence
5.3. Value Chain Analysis
5.4. COVID-19 Impact Analysis
6. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Product
6.1. Key Findings/Developments
6.2. Introduction & Definition
6.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
6.3.1. Pacemakers
6.3.1.1. Single-chamber
6.3.1.2. Dual-chamber
6.3.1.3. Biventricular
6.3.2. Implantable Cardioverter Defibrillator
6.3.2.1. Transvenous ICD
6.3.2.2. Subcutaneous ICD
6.3.3. Implantable Cardiac Loop Recorders
6.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product
7. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Application
7.1. Key Findings/Developments
7.2. Introduction & Definition
7.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
7.3.1. Arrhythmia
7.3.2. Heart Rhythm Monitoring
7.3.3. Heart Block/Failure
7.3.4. Others
7.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application
8. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by End-user
8.1. Key Findings/Developments
8.2. Introduction & Definition
8.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user
9. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Region
9.1. Geographical Representation
9.2. Global Cardiac Implantable Electronic Device Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Region
10. North America Cardiac Implantable Electronic Device Market Analysis and Forecast
10.1. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Country, 2017–2031
10.2. North America Cardiac Implantable Electronic Device Market Value Forecast, by Country, 2017–2031
10.2.1. U.S.
10.2.2. Canada
10.3. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
10.4. North America Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
10.4.1. Pacemakers
10.4.1.1. Single-chamber
10.4.1.2. Dual-chamber
10.4.1.3. Biventricular
10.4.2. Implantable Cardioverter Defibrillators
10.4.2.1. Transvenous ICD
10.4.2.2. Subcutaneous ICD
10.4.3. Implantable Cardiac Loop Recorders
10.5. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
10.6. North America Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
10.6.1. Arrhythmia
10.6.2. Heart Rhythm Monitoring
10.6.3. Heart Block/Failure
10.6.4. Others
10.7. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
10.8. North America Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
10.8.1. Hospitals
10.8.2. Ambulatory Surgical Centers
10.8.3. Others
10.9. North America Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
10.9.1. By Country
10.9.2. By Product
10.9.3. By Application
10.9.4. By End-user
11. Europe Cardiac Implantable Electronic Device Market Analysis and Forecast
11.1. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031
11.1.1. Germany
11.1.2. France
11.1.3. U.K.
11.1.4. Spain
11.1.5. Italy
11.1.6. Rest of Europe
11.2. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
11.3. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
11.3.1. Pacemakers
11.3.1.1. Single-chamber
11.3.1.2. Dual-chamber
11.3.1.3. Biventricular
11.3.2. Implantable Cardioverter Defibrillators
11.3.2.1. Transvenous ICD
11.3.2.2. Subcutaneous ICD
11.3.3. Implantable Cardiac Loop Recorders
11.4. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
11.5. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
11.5.1. Arrhythmia
11.5.2. Heart Rhythm Monitoring
11.5.3. Heart Block/Failure
11.5.4. Others
11.6. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
11.7. Europe Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
11.7.1. Hospitals
11.7.2. Ambulatory Surgical Centers
11.7.3. Others
11.8. Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
11.8.1. By Country/Sub-region
11.8.2. By Product
11.8.3. By Application
11.8.4. By End-user
12. Asia Pacific Cardiac Implantable Electronic Device Market Analysis and Forecast
12.1. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031
12.1.1. China
12.1.2. Japan
12.1.3. India
12.1.4. Australia & New Zealand
12.1.5. Rest of Asia Pacific
12.2. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
12.3. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
12.3.1. Pacemakers
12.3.1.1. Single-chamber
12.3.1.2. Dual-chamber
12.3.1.3. Biventricular
12.3.2. Implantable Cardioverter Defibrillators
12.3.2.1. Transvenous ICD
12.3.2.2. Subcutaneous ICD
12.3.3. Implantable Cardiac Loop Recorders
12.4. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
12.5. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
12.5.1. Arrhythmia
12.5.2. Heart Rhythm Monitoring
12.5.3. Heart Block/Failure
12.5.4. Others
12.6. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
12.7. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
12.7.1. Hospitals
12.7.2. Ambulatory Surgical Centers
12.7.3. Others
12.8. Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
12.8.1. By Country/Sub-region
12.8.2. By Product
12.8.3. By Application
12.8.4. By End-user
13. Latin America Cardiac Implantable Electronic Device Market Analysis and Forecast
13.1. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017-2027
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Rest of Latin America
13.2. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
13.3. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
13.3.1. Pacemakers
13.3.1.1. Single-chamber
13.3.1.2. Dual-chamber
13.3.1.3. Biventricular
13.3.2. Implantable Cardioverter Defibrillators
13.3.2.1. Transvenous ICD
13.3.2.2. Subcutaneous ICD
13.3.3. Implantable Cardiac Loop Recorders
13.4. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
13.5. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
13.5.1. Arrhythmia
13.5.2. Heart Rhythm Monitoring
13.5.3. Heart Block/Failure
13.5.4. Others
13.6. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
13.7. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
13.7.1. Hospitals
13.7.2. Ambulatory Surgical Centers
13.7.3. Others
13.8. Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
13.8.1. By Country/Sub-region
13.8.2. By Product
13.8.3. By Application
13.8.4. By End-user
14. Middle East & Africa Cardiac Implantable Electronic Device Market Analysis and Forecast
14.1. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031
14.1.1. GCC Countries
14.1.2. South Africa
14.1.3. Rest of Middle East & Africa
14.2. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031
14.3. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031
14.3.1. Pacemakers
14.3.1.1. Single-chamber
14.3.1.2. Dual-chamber
14.3.1.3. Biventricular
14.3.2. Implantable Cardioverter Defibrillators
14.3.2.1. Transvenous ICD
14.3.2.2. Subcutaneous ICD
14.3.3. Implantable Cardiac Loop Recorders
14.4. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031
14.5. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031
14.5.1. Arrhythmia
14.5.2. Heart Rhythm Monitoring
14.5.3. Heart Block/Failure
14.5.4. Others
14.6. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031
14.7. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031
14.7.1. Hospitals
14.7.2. Ambulatory Surgical Centers
14.7.3. Others
14.8. Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)
14.8.1. By Country/Sub-region
14.8.2. By Product
14.8.3. By Application
14.8.4. By End-user
15. Competition Landscape
15.1. Competition Matrix
15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.2.1. Medtronic plc (HQ, Business Segments, Employee Strength)
15.2.1.1. Company Details
15.2.1.2. Company Description
15.2.1.3. Business Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Financial Analysis
15.2.1.6. Strategic Overview
15.2.2. Biotronic AG (HQ, Business Segments, Employee Strength)
15.2.2.1. Company Details
15.2.2.2. Company Description
15.2.2.3. Business Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Abbott Laboratories (HQ, Business Segments, Employee Strength)
15.2.3.1. Company Details
15.2.3.2. Company Description
15.2.3.3. Business Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Angel Medical Systems, Inc. (HQ, Business Segments, Employee Strength)
15.2.4.1. Company Details
15.2.4.2. Company Description
15.2.4.3. Business Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Boston Scientific Corporation (HQ, Business Segments, Employee Strength)
15.2.5.1. Company Details
15.2.5.2. Company Description
15.2.5.3. Business Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Financial Analysis
15.2.5.6. Strategic Overview
15.2.6. MicroPort (HQ, Business Segments, Employee Strength)
15.2.6.1. Company Details
15.2.6.2. Company Description
15.2.6.3. Business Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Financial Analysis
15.2.6.6. Strategic Overview
15.2.7. Lepu Medical Technology (Beijing) Co., Ltd. (HQ, Business Segments, Employee Strength)
15.2.7.1. Company Details
15.2.7.2. Company Description
15.2.7.3. Business Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Financial Analysis
15.2.7.6. Strategic Overview
15.2.8. MEDICO S.R.L. (HQ, Business Segments, Employee Strength)
15.2.8.1. Company Details
15.2.8.2. Company Description
15.2.8.3. Business Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Financial Analysis
15.2.8.6. Strategic Overview
15.2.9. Vitatron (HQ, Business Segments, Employee Strength)
15.2.9.1. Company Details
15.2.9.2. Company Description
15.2.9.3. Business Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Financial Analysis
15.2.9.6. Strategic Overview
15.2.10. Cook Medical Inc. (HQ, Business Segments, Employee Strength)
15.2.10.1. Company Details
15.2.10.2. Company Description
15.2.10.3. Business Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Financial Analysis
15.2.10.6. Strategic Overview
List of Tables
Table 01: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers 2017–2031
Table 03: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031
Table 04: Global Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 09: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031
Table 10: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031
Table 11: North America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: North America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031
Table 16: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031
Table 17: Europe Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Europe Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 21: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031
Table 22: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031
Table 23: Asia Pacific Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Asia Pacific Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 27: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031
Table 28: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031
Table 29: Latin America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Latin America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 31: Middle East & Africa Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 33: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031
Table 34: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, Implantable Cardioverter Defibrillators, 2017–2031
Table 35: Middle East & Africa Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 36: Middle East & Africa Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Cardiac Implantable Electronic Device Market Value Share, by Region, 2021
Figure 03: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021 and 2031
Figure 04: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product 2022–2031
Figure 05: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Pacemakers, 2017–2031
Figure 06: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Implantable Cardioverter Defibrillators, 2017–2031
Figure 07: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Implantable Cardiac Loop Recorders, 2017–2031
Figure 08: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031
Figure 09: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031
Figure 10: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Arrhythmia, 2017–2031
Figure 11: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Heart Rhythm Monitoring, 2017–2031
Figure 12: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Heart Block/Failure, 2017–2031
Figure 13: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Others, 2017–2031
Figure 14: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021 and 2031
Figure 15: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031
Figure 16: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 17: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 18: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Others, 2017–2031
Figure 19: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by Region, 2021 and 2031
Figure 20: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Region, 2022–2031
Figure 21: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 22: North America Cardiac Implantable Electronic Device Market Value Share (%), by Country, 2021 and 2031
Figure 23: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country, 2022–2031
Figure 24: North America Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031
Figure 25: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031
Figure 26: North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031
Figure 27: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031
Figure 28: North America Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031
Figure 29: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031
Figure 30: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 31: Europe Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 32: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 33: Europe Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031
Figure 34: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031
Figure 35: Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031
Figure 36: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031
Figure 37: Europe Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031
Figure 38: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031
Figure 39: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 40: Asia Pacific Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 41: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 42: Asia Pacific Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031
Figure 43: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031
Figure 44: Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031
Figure 45: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031
Figure 46: Asia Pacific Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031
Figure 47: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031
Figure 48: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 49: Latin America Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 50: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 51: Latin America Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031
Figure 52: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031
Figure 53: Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031
Figure 54: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031
Figure 55: Latin America Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031
Figure 56: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031
Figure 57: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 58: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 59: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 60: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031
Figure 61: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031
Figure 62: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031
Figure 63: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031
Figure 64: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031
Figure 65: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cardiac Implantable Electronic Device Market
